BioSpace News Archive

Imagion Biosystems Limited (ASX: IBX) (the Company), a company dedicated to improving healthcare through the earlier detection of cancer, today announces appointments to its newly established Scientific Advisory Board.

Apexigen, Inc. announced today that Xiaodong Yang, M.D., Ph.D., President & Chief Executive Officer, will present at the upcoming Solebury Trout Private Company Showcase at the offices of Davis Polk & Wardwell, LLP in New York on Friday, October 18, 2019 at 11:40am EDT.

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company’s Chief Executive Officer Yehiel Tal will present at the Dawson James 5th Annual Small Cap Growth Conference on Tuesday, October 29, 2019 at 1:10 p.m. ET

Fidmi Medical Ltd. a portfolio company of The Trendlines Group Ltd. (“Trendlines”) (SGX: 42T) (OTCQX: TRNLY), announced today that it received 510K regulatory clearance from the United States Food and Drug Administration (FDA) for its low-profile enteral feeding device.

For the first time, Bright Health will offer individual and family plans and Medicare Advantage plans in Florida.

Enzychem Lifesciences, a leading global biopharmaceutical company focusing on innovative new drug development for unmet medical needs, today announced that three abstracts have been accepted for poster presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, on October 26-30, 2019, at the Hynes Convention Center in Boston, Massachusetts.

Hospitals and health systems looking to establish brand dominance, competitive distinction and clinical excellence in diabetes care can turn to a team of experts at Glytec dedicated to helping facilitate full adoption of best practices.

Greenleaf Health, a leading Food and Drug Administration regulatory consulting firm, announces that the firm has expanded its compliance and manufacturing portfolio to include Good Clinical Practice services.

Noblegen Inc., an advanced nutritional ingredient company, is excited to announce that Brendan Brazier, the co-founder of Vega, best-selling author of the Thrive book series, and editor in chief of Alive magazine, has joined Noblegen as their VP of Food Architecture.

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it has increased its minority equity stake to 49 percent in Daikyo Seiko, Ltd.